Fol. Biol. 2015, 61, 203-218
https://doi.org/10.14712/fb2015061060203
Circulating MicroRNAs: Methodological Aspects in Detection of These Biomarkers
References
1. 2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 108, 5003-5008.
< , J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., Tait, J. F., Tewari, M. (https://doi.org/10.1073/pnas.1019055108>
2. 2010) MicroRNA profiling: separating signal from noise. Nat. Methods 7, 687-692.
< , M. (https://doi.org/10.1038/nmeth0910-687>
3. 2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
< , D. P. (https://doi.org/10.1016/S0092-8674(04)00045-5>
4. 2015) ExcellmiRDB for translational genomics: a curated online resource for extracellular microRNAs. OMICS 19, 24-30.
< , J. K., Saini, A. K., Chand, T., Meena, A., Beniwal, S., Suthar, J. R., Meena, N., Kachhwaha, S., Kothari, S. L. (https://doi.org/10.1089/omi.2014.0106>
5. 2010) Expression profiling of micro- RNA using real-time quantitative PCR, how to use it and what is available. Methods 50, 244-249.
< , V., Castoldi, M. (https://doi.org/10.1016/j.ymeth.2010.01.026>
6. 2014) MicroRNAs in mesenteric lymph and plasma during acute pancreatitis. Ann. Surg. 260, 341-347.
< , C., Askelund, K. J., Shanbhag, S. T., Chakraborty, M., Petrov, M. S., Delahunt, B., Windsor, J. A., Phillips, A. R. (https://doi.org/10.1097/SLA.0000000000000447>
7. 2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1-S6.
< , T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M., Dahlsveen, I. K. (https://doi.org/10.1016/j.ymeth.2012.09.015>
8. 2013) Exosomes as nucleic acid nanocarriers. Adv. Drug Deliv. Rev. 65, 331-335.
< , J. G., Dassler, J., Coch, C., Schlee, M., Hartmann, G. (https://doi.org/10.1016/j.addr.2012.06.011>
9. 2013) Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA- 150 to effector T cells to inhibit contact sensitivity. J. Allergy Clin. Immunol. 132, 170-181.
< , K., Ptak, W., Jayakumar, A., Püllmann, K., Caplan, M. J., Chairoungdua, A., Lu, J., Adams, B. D., Sikora, E., Nazimek, K., Marquez, S., Kleinstein, S. H., Sangwung, P., Iwakiri, Y., Delgato, E., Redegeld, F., Blokhuis, B. R., Wojcikowski, J., Daniel, A. W., Groot Kormelink, T., Askenase, P. W. (https://doi.org/10.1016/j.jaci.2013.04.048>
10. 2012) Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 7, e45105.
< , M., Dugo, M., Musella, V., Marchesi, E., Chiorino, G., Grand, M. M., Pierotti, M. A., Daidone, M. G., Canevari, S., De Cecco, L. (https://doi.org/10.1371/journal.pone.0045105>
11. 2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006.
< , X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., Li, Q., Li, X., Wang, W., Zhang, Y., Wang, J., Jiang, X., Xiang, Y., Xu, C., Zheng, P., Zhang, J., Li, R., Zhang, H., Shang, X., Gong, T., Ning, G., Wang, J., Zen, K., Zhang, J., Zhang, C. Y. (https://doi.org/10.1038/cr.2008.282>
12. 2013) A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs. PLoS One 8, e79652.
< , X., Liang, H., Guan, D., Wang, C., Hu, X., Cui, L., Chen, S., Zhang, C., Zhang, J., Zen, K., Zhang, C. Y. (https://doi.org/10.1371/journal.pone.0079652>
13. 2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 8, e64795.
< , H. H., Yi, H. S., Kim, Y., Kroh, E. M., Chien, J. W., Eaton, K. D., Goodman, M. T., Tait, J. F., Tewari, M., Pritchard, C. C. (https://doi.org/10.1371/journal.pone.0064795>
14. 2008) Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482-490.
< , S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., Lo, Y. M. (https://doi.org/10.1373/clinchem.2007.097972>
15. 2009) Shedding microvesicles: artefacts no more. Trends Cell. Biol. 19, 43-51.
< , E., Racchetti, G., Meldolesi, J. (https://doi.org/10.1016/j.tcb.2008.11.003>
16. 2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Exp. Opin. Biol. Ther. 9, 703-711.
< , M. A., Calin, G. A. (https://doi.org/10.1517/14712590902932889>
17. 2009) Expression profiling of microRNAs by deep sequencing. Brief Bioinform. 10, 490-497.
< , C. J., Reid, J. G., Gunaratne, P. H. (https://doi.org/10.1093/bib/bbp019>
18. 2013) Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer 132, 1602-1612.
< , K., Zucknick, M., Heil, J., Madhavan, D., Schott, S., Turchinovich, A., Arlt, D., Rath, M., Sohn, C., Benner, A., Junkermann, H., Schneeweiss, A., Burwinkel, B. (https://doi.org/10.1002/ijc.27799>
19. 2012) Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93, 633-644.
< , P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., Ziemann, M., Helbing, T., El-Osta, A., Jowett, J. B., Peter, K. (https://doi.org/10.1093/cvr/cvs007>
20. 2011) Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6, e20769.
< , R., Jiang, R., Gollub, J., Getts, R. C., Jones, K. W. (https://doi.org/10.1371/journal.pone.0020769>
21. 2004) Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50, 564-573.
< , T., Raja, S., Kelly, L., Bigbee, W. L., Kirkwood, J. M., Luketich, J. D., Godfrey, T. E. (https://doi.org/10.1373/clinchem.2003.028506>
22. 2012) Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann. Hematol. 91, 553-559.
< , C., Zhu, D. X., Dong, H. J., Zhou, Z. J., Wang, Y. H., Liu, L., Fan, L., Miao, K. R., Liu, P., Xu, W., Li, J. Y. (https://doi.org/10.1007/s00277-011-1350-9>
23. 2013) Circulating miR- 150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J. Transl. Med. 11, 31.
< , H., Bitar, N., Najar, M., Lewalle, P., Fayyad- Kazan, M., Badran, R., Hamade, E., Daher, A., Hussein, N., ElDirani, R., Berri, F., Vanhamme, L., Burny, A., Martiat, P., Rouas, R., Badran, B. (https://doi.org/10.1186/1479-5876-11-31>
24. 2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31, 2383-2390.
< , S., Zeiher, A. M., Dimmeler, S. (https://doi.org/10.1161/ATVBAHA.111.226696>
25. 2014) Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann. Rheum. Dis. 73, 1898-1904.
< , M., Aradi, B., Senolt, L., Ospelt, C., Vettori, S., Mann, H., Filer, A., Raza, K., Buckley, C. D., Snow, M., Vencovsky, J., Pavelka, K., Michel, B. A., Gay, R. E., Gay, S., Jüngel, A. (https://doi.org/10.1136/annrheumdis-2012-202815>
26. 2012) Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30, 1985-1998.
< , V., Collino, F., Herrera, M. B., Cavallari, C., Deregibus, M. C., Cisterna, B., Bruno, S., Romagnoli, R., Salizzoni, M., Tetta, C., Camussi, G. (https://doi.org/10.1002/stem.1161>
27. 2008) Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 26, 407-415.
< , M. R., Chen, W., Adamidi, C., Maaskola, J., Einspanier, R., Knespel, S., Rajewsky, N. (https://doi.org/10.1038/nbt1394>
28. 2011) Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington’s disease. Hum. Mol. Genet. 20, 2225-2237.
< , P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., Björkqvist, M. (https://doi.org/10.1093/hmg/ddr111>
29. 2014) miRNA in plasma exosome is stable under different storage conditions. Molecules 19, 1568-1575.
< , Q., Zhou, Y., Lu, J., Bai, Y., Xie, X., Lu, Z. (https://doi.org/10.3390/molecules19021568>
30. 2015) Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia. Int. J. Mol. Med. 35, 81-91.
< , Q., Zhu, Y., Li, H., Tian, F., Xie, X., Bai, Y. (https://doi.org/10.3892/ijmm.2014.1989>
31. 2008) Serum microRNAs are promising novel biomarkers. PLoS One. 3, e3148.
< , S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., Bentwich, Z., Hod, M., Goren, Y., Chajut, A. (https://doi.org/10.1371/journal.pone.0003148>
32. 2010) Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16, 991-1006.
< , A., Dvinge, H., Salmon-Divon, M., Osborne, M., Kutter, C., Hadfield, J., Bertone, P., Caldas, C. (https://doi.org/10.1261/rna.1947110>
33. 2013) Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 15, R42.
< , A. C., Xu, Z., Weinberg, C. R., Getts, R. C., Wade, P. A., DeRoo, L. A., Sandler, D. P., Taylor, J. A. (https://doi.org/10.1186/bcr3428>
34. 2013) A review of computational tools in microRNA discovery. Front. Genet. 4, 81.
< , C. P. C., Cho, J.-H., Hood, L., Franco, O. L., Pereira, R. W., Wang, K. (https://doi.org/10.3389/fgene.2013.00081>
35. 2013) Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. Blood 121, 4977-4984.
< , S., Sorrentino, A., Langer, C., Buske, C., Döhner, H., Mertens, D., Kuchenbauer, F. (https://doi.org/10.1182/blood-2013-01-480079>
36. 2012) Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. J. Neurochem. 122, 641-649.
< , H., Li, H., Zhang, L., Luan, H., Huang, T., Wang, L., Fan, Y., Zhang, Y., Liu, X., Wang, W., Yuan, Z. (https://doi.org/10.1111/j.1471-4159.2012.07812.x>
37. 2011) Serum microRNA expression in pregnancies with preeclampsia. Genet. Mol. Res. 10, 4034-4040.
< , T., Zeybek, Y. G., Akçakaya, P., Kalelioğlu, I., Benian, A., Ermis, H., Aydınlı, K. (https://doi.org/10.4238/2011.November.8.5>
38. 2009) miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 37, 68-76.
< , M., Sturm, M., Langenberger, D., Falcón-Pérez, J. M., Aransay, A. M. (https://doi.org/10.1093/nar/gkp347>
39. 2014) Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion. Oncol. Lett. 8, 1889-1895.
< , H. S., Jo, Y. N., Lee, J. Y., Choi, S. Y., Jeong, Y., Yun, J., Lee, O. J. (https://doi.org/10.3892/ol.2014.2404>
40. 2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661.
< , M., Hoefig, K., Merz, H., Feller, A. C., Kausch, I., Jocham, D., Warnecke, J. M., Sczakiel, G. (https://doi.org/10.1016/j.urolonc.2009.01.027>
41. 2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
< , L., Hannon, G. J. (https://doi.org/10.1038/nrg1379>
42. 2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat. Methods 10, 1003-1005.
< , C. M., Chevillet, J. R., Briggs, H. A., Gallichotte, E. N., Ruf, I. K., Hindson, B. J., Vessella, R. L., Tewari, M. (https://doi.org/10.1038/nmeth.2633>
43. 2010) Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3, 109-113.
< , A. S., Huang, X., Cao, H., Christman-Skieller, C., Bennewith, K., Le, Q. T., Koong, A. C. (https://doi.org/10.1593/tlo.09256>
44. 2008) Deep cap analysis gene expression (CAGE): genome-wide identification of promoters, quantification of their expression, and network inference. Biotechniques 44, 627-632.
< , M., Hayashizaki, Y. (https://doi.org/10.2144/000112802>
45. 2012) Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Med. Oncol. 29, 2402-2408.
< , J. J., Yu, J., Li, J. Y., Liu, Y. T., Zhong, R. Q. (https://doi.org/10.1007/s12032-012-0210-3>
46. 2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694.
< , M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M. L., Schmittgen, T. D., Nana-Sinkam, S. P., Jarjoura, D., Marsh, C. B. (https://doi.org/10.1371/journal.pone.0003694>
47. 2012) Plasma microRNA-21 concentration may be a useful biomarker in glioblastoma patients. Cancer Invest. 30, 615-621.
< , A., Wagner, L., Wöhrer, A., Furtner, J., Widhalm, G., Marosi, C., Preusser, M. (https://doi.org/10.3109/07357907.2012.708071>
48. 2012) Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol. 36, 560-565.
< , K., Sasaki, D., Tsuruda, K., Inokuchi, N., Nagai, K., Hasegawa, H., Yanagihara, K., Kamihira, S. (https://doi.org/10.1016/j.canep.2012.07.002>
49. 2013) Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell. Mol. Neurobiol. 33, 601-613.
< , X. F., Wu, N., Wang, L., Li, J. (https://doi.org/10.1007/s10571-013-9940-9>
50. 2012) Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. Br. J. Cancer 107, 1987-1996.
< , C. I., Zabolotskaya, M. V., King, A. J., Stewart, H. J., Horne, G. A., Chevassut, T. J., Newbury, S. F. (https://doi.org/10.1038/bjc.2012.525>
51. 2014) Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma. Clin. Cancer Res. 20, 253-264.
< , K., Nourse, J. P., Keane, C., Bhatnagar, A., Gandhi, M. K. (https://doi.org/10.1158/1078-0432.CCR-13-1024>
52. 2012) Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118, 2603-2614.
< , E. J., Santarpia, L., Kim, J., Esteva, F. J., Moretti, E., Buzdar, A. U., Di Leo, A., Le, X. F., Bast, R. C. Jr, Park, S. T., Pusztai, L., Calin, G. A. (https://doi.org/10.1002/cncr.26565>
53. 2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6, e24145.
< , M. B., Kao, S. C., Edelman, J. J., Armstrong, N. J., Vallely, M. P., van Zandwijk, N., Reid, G. (https://doi.org/10.1371/journal.pone.0024145>
54. 2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301.
< , E. M., Parkin, R. K., Mitchell, P. S., Tewari, M. (https://doi.org/10.1016/j.ymeth.2010.01.032>
55. 2009) Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 55, 1977-1983.
< , O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., Johnson, J. M., Sina, J. F., Fare, T. L., Sistare, F. D., Glaab, W. E. (https://doi.org/10.1373/clinchem.2009.131797>
56. 2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675.
< , C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., Hatton, C. S., Harris, A. L. (https://doi.org/10.1111/j.1365-2141.2008.07077.x>
57. 2010) Regulation and biological function of the liver-specific miR-122. Biochem. Soc. Trans. 38, 1553-1557.
< A. P., Jopling C. L. (https://doi.org/10.1042/BST0381553>
58. 2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
< , B. P., Burge, C. B., Bartel, D. P. (https://doi.org/10.1016/j.cell.2004.12.035>
59. 2012) A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing. Clin. Chim. Acta 413, 568-576.
< , H., Guo, L., Wu, Q., Lu, J., Ge, Q., Lu, Z. (https://doi.org/10.1016/j.cca.2011.11.026>
60. 2013) Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed. Res. Int. 2013, 970265.
, H., Ge, Q., Guo, L., Lu, Z. (
61. 2012) Method for microRNA isolation from clinical serum samples. Anal. Biochem. 431, 69-75.
< , Y., Kowdley, K. V. (https://doi.org/10.1016/j.ab.2012.09.007>
62. 2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8, 166.
< , Y., Ridzon, D., Wong, L., Chen, C. (https://doi.org/10.1186/1471-2164-8-166>
63. 2012) High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol. 29, 618-626.
< , X. G., Zhu, W. Y., Huang, Y. Y., Ma, L .N., Zhou, S. Q., Wang, Y. K., Zeng, F., Zhou, J. H., Zhang, Y. K. (https://doi.org/10.1007/s12032-011-9923-y>
64. 2014) Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder. J. Affect. Disord. 163, 133-139.
< , X., Zhang, L., Cheng, K., Wang, X., Ren, G., Xie, P. (https://doi.org/10.1016/j.jad.2013.12.035>
65. 2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
< , J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., Golub, T. R. (https://doi.org/10.1038/nature03702>
66. 2013) MicroRNAs involved in skeletal muscle differentiation. J. Genet. Genomics 40, 107-116.
< , W., Nie, Q., Zhang, X. (https://doi.org/10.1016/j.jgg.2013.02.002>
67. 2010) High-throughput SuperSAGE for digital gene expression analysis of multiple samples using next generation sequencing. PLoS One 5, e12010.
< , H., Yoshida, K., Luo, S., Kimura, E., Fujibe, T., Albertyn, Z., Barrero, R. A., Krüger, D. H., Kahl, G., Schroth, G. P., Terauchi, R. (https://doi.org/10.1371/journal.pone.0012010>
68. 2014) Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries. Cancer Epidemiol. Biomarkers Prev. 23, 2638-2642.
< , E., Saccenti, E., Lupini, L., Callegari, E., Negrini, M., Ferracin, M. (https://doi.org/10.1158/1055-9965.EPI-14-0503>
69. 2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105, 10513-10518.
< , P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O’Briant, K. C., Allen, A., Lin, D. W., Urban, N., Drescher, C. W., Knudsen, B. S., Stirewalt, D. L., Gentleman, R., Vessella, R. L., Nelson, P. S., Martin, D. B., Tewari, M. (https://doi.org/10.1073/pnas.0804549105>
70. 2010) Identification of pregnancy-associated microRNAs in maternal plasma. Clin. Chem. 56, 1767-1771.
< , K., Miura, S., Yamasaki, K., Higashijima, A., Kinoshita, A., Yoshiura, K., Masuzaki, H. (https://doi.org/10.1373/clinchem.2010.147660>
71. 2014) Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells. BMC Genomics 15, 395.
< , M., Bonnel, S., Gostan, T., Blanchard, D., Courgnaud, V., Lecellier. C. H. (https://doi.org/10.1186/1471-2164-15-395>
72. 2013) Assessing an improved protocol for plasma microRNA extraction. PLoS One 8, e82753.
< , I., Sánchez-Izquierdo, D., Iborra, M., Tortosa, L., Navarro-Puche, A., Nos, P., Cervera, J., Beltrán, B. (https://doi.org/10.1371/journal.pone.0082753>
73. 2010) The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31, 781-784.
< , J. F., Chu, T., Hubel, C. A., Nelson, D. M., Parks, W. T., Sadovsky, Y. (https://doi.org/10.1016/j.placenta.2010.07.001>
74. 2011) MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 108, 6573-6578.
< , E., Wang, K., Cho, J. H., van Moer, K., Pierson, S., Paggetti, J., Nazarov, P. V., Palissot, V., Hood, L. E., Berchem, G., Galas, D. J. (https://doi.org/10.1073/pnas.1019557108>
75. 2010) Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611.
< , V., Clancy, J. W., Sedgwick, A., D’Souza-Schorey, C. (https://doi.org/10.1242/jcs.064386>
76. 2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375-1381.
< , E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., Poon, T. C., Ng, S. S., Sung, J. J. (https://doi.org/10.1136/gut.2008.167817>
77. 2012) Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual β-cell function and glycaemic control during disease progression. Exp. Diabetes Res. 2012, 896362.
, L. B., Wang, C., Sørensen, K., Bang-Berthelsen, C. H., Hansen, L., Andersen, M. L., Hougaard, P., Juul, A., Zhang, C. Y., Pociot, F., Mortensen, H. B. (
78. 2013) Age-related changes in microRNA levels in serum. Aging 5, 725-740.
Hooten, N., Fitzpatrick, M., Wood, W. H., De, S., Ejiogu, N., Zhang, Y., Mattison, J. A., Becker, K. G., Zonderman, A. B., Evans, M. K. (
79. 2007) Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers. Anticancer Res. 27, 1257-1265.
, L. (
80. 2010) Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR- 92a. BMC Res. Notes 3, 347.
< , J. H., Umezu, T., Kobayashi, C., Hamamura, R. S., Tanaka, M., Kuroda, M., Ohyashiki, K. (https://doi.org/10.1186/1756-0500-3-347>
81. 2011) Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin’s lymphoma. PLoS One 6, e16408.
< , K., Umezu, T., Yoshizawa, S., Ito, Y., Ohyashiki, M., Kawashima, H., Tanaka, M., Kuroda, M., Ohyashiki, J. H. (https://doi.org/10.1371/journal.pone.0016408>
82. 2013) Targeting the circulating microRNA signature of obesity. Clin. Chem. 59, 781-792.
< , F. J., Mercader, J. M., Catalán, V., Moreno-Navarrete, J. M., Pueyo, N., Sabater, M., Gómez-Ambrosi, J., Anglada, R., Fernández-Formoso, J. A., Ricart, W., Frühbeck, G., Fernández-Real, J. M. (https://doi.org/10.1373/clinchem.2012.195776>
83. 2009) Prediction of novel microRNA genes in cancer-associated genomic regions – a combined computational and experimental approach. Nucleic Acids Res. 37, 3276-3287.
< , A., Boutla, A., Gkirtzou, K., Reczko, M., Kalantidis, K., Poirazi, P. (https://doi.org/10.1093/nar/gkp120>
84. 2009) Salivary micro- RNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15, 5473-5477.
< , N. J., Zhou, H., Elashoff, D., Henson, B. S., Kastratovic, D. A., Abemayor, E., Wong, D. T. (https://doi.org/10.1158/1078-0432.CCR-09-0736>
85. 2010) Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. Biotechniques 48, 219-222.
< , S., Weber, J., Lemoine, F., Consales, F., Paillusson, A., Dupasquier, M., Thomas, J., Richter, H., Kaessmann, H., Beaudoing, E., Hagenbüchle, O., Harshman, K. (https://doi.org/10.2144/000113367>
86. 2013) Changes in circulating microRNAs are associated with childhood obesity. J. Clin. Endocrinol. Metab. 98, 1655-1660.
< , A., Ortega, F. J., Mercade, J. M., Moreno-Navarrete, J. M., Moreno, M., Bonet, N., Ricart, W., López- Bermejo, A., Fernández-Real, J. M. (https://doi.org/10.1210/jc.2013-1496>
87. 2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. 5, 492-497.
< , C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., Tait, J. F., Tewari, M. (https://doi.org/10.1158/1940-6207.CAPR-11-0370>
88. 2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10, 42-46.
< , G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., Kloecker, G. H. (https://doi.org/10.3816/CLC.2009.n.006>
89. 2010) The miR-144/451 locus is required for erythroid homeostasis. J. Exp. Med. 207, 1351-1358.
< , K. D., Simmini, S., Abreu-Goodger, C., Bartonicek, N., Di Giacomo, M., Bilbao-Cortes, D., Horos, R., Von Lindern, M., Enright, A. J., O’Carroll, D. (https://doi.org/10.1084/jem.20100458>
90. 2013) Circulating microRNA profile throughout the menstrual cycle. PLoS One 8, e81166.
< , K., Saare, M., Roost, A. M., Salumets, A., Peters, M. (https://doi.org/10.1371/journal.pone.0081166>
91. 2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112, 55-59.
< , K. E., Alder, H., Hagan, J. P., Richardson, D. L., Croce, C. M., Cohn, D. E. (https://doi.org/10.1016/j.ygyno.2008.08.036>
92. 2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579.
< , E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., Olson, E. N. (https://doi.org/10.1126/science.1139089>
93. 2012) miRandola: extracellular circulating microRNAs database. PLoS One 7, e47786.
< , F., Di Bella, S., Nigita, G., Macca, V., Laganà, A., Giugno, R., Pulvirenti, A., Ferro, A. (https://doi.org/10.1371/journal.pone.0047786>
94. 2008) High-throughput real-time PCR. Methods Mol. Biol. 429, 89-98.
< , T. D., Lee, E. J., Jiang, J. (https://doi.org/10.1007/978-1-60327-040-3_7>
95. 2011) Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11, 374.
< , J., Liu, Z., Todd, N. W., Zhang, H., Liao, J., Yu, L., Guarnera, M. A., Li, R., Cai, L., Zhan, M., Jiang, F. (https://doi.org/10.1186/1471-2407-11-374>
96. 2009) Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6, 267-283.
< , R. J., Lim, J. W., Moritz, R. L., Mathivanan, S. (https://doi.org/10.1586/epr.09.17>
97. 2013) Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls. BMC Vet. Res. 9, 12.
< , C., Bauersachs, S., Weber, K., Wess, G. (https://doi.org/10.1186/1746-6148-9-12>
98. 2013a) MicroRNAs: regulators of neuronal fate. Curr. Opin. Cell Biol. 25, 215-221.
< , A. X., Crabtree, G. R., Yoo, A. S. (https://doi.org/10.1016/j.ceb.2012.12.007>
99. 2013b) MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma. Acta Gastroenterol. Belg. 76, 386-392.
, L., Hu, J., Xiong, W., Chen, X., Li, H., Jie, S. (
100. 2012) Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One 7, e47003.
< , Y., Wang, M., Lin, G., Sun, S., Li, X., Qi, J., Li, J. (https://doi.org/10.1371/journal.pone.0047003>
101. 2014) Circulating miR-125b as a biomarker of Alzheimer’s disease. J. Neurol. Sci. 336, 52-56.
< , L., Yu, J. T., Liu, Q. Y., Tan, M. S., Zhang, W., Hu, N., Wang, Y. L., Sun, L., Jiang, T., Tan, L. (https://doi.org/10.1016/j.jns.2013.10.002>
102. 2009) Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 4, e5532.
< , M., Oikawa, K., Takanashi, M., Kudo, M., Ohyashiki, J., Ohyashiki, K., Kuroda, M. (https://doi.org/10.1371/journal.pone.0005532>
103. 2013) Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur. J. Cancer Prev. 22, 540-548.
< , D., Shen, Y., Wang, M., Yang, R., Wang, Z., Sui, A., Jiao, W., Wang, Y. (https://doi.org/10.1097/CEJ.0b013e32835f3be9>
104. 2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48, 1647-1653.
< , N. B., Ng, E. K., Lo, Y. M. (https://doi.org/10.1093/clinchem/48.10.1647>
105. 2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233.
< , A., Weiz, L., Langheinz, A., Burwinkel, B. (https://doi.org/10.1093/nar/gkr254>
106. 2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32, 2747-2755.
< , T., Ohyashiki, K., Kuroda, M., Ohyashiki, J. H. (https://doi.org/10.1038/onc.2012.295>
107. 2014) Potential role of circulating microRNAs as early markers of preeclampsia. Taiwan J. Obstet. Gynecol. 53, 232-234.
< , B., Feriotto, G., Monasta, L., Bilel, S., Zweyer, M., Celeghini, C. (https://doi.org/10.1016/j.tjog.2014.03.001>
108. 2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433.
< , K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., Remaley, A. T. (https://doi.org/10.1038/ncb2210>
109. 2013) Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int. J. Cardiol. 167, 2875-2881.
< , A. V., García, R., Merino, D., Llano, M., Cobo, M., Montalvo, C., Martín-Durán, R., Hurlé, M. A., Nistal, J. F. (https://doi.org/10.1016/j.ijcard.2012.07.021>
110. 2013) Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980.
< , C., Gutiérrez-Vázquez, C., Sánchez-Cabo, F., Pérez-Hernández, D., Vázquez, J., Martin-Cofreces, N., Martinez-Herrera, D. J., Pascual-Montano, A., Mittelbrunn, M., Sánchez-Madrid, F. (https://doi.org/10.1038/ncomms3980>
111. 2011) Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 6, e17167.
< , B., Howel, P., Bruheim, S., Ju, J., Owen, L. B., Fodstad, O., Xi, Y. (https://doi.org/10.1371/journal.pone.0017167>
112. 2012) The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J. Cancer Res. Clin. Oncol. 138, 1659-1666.
< , B., Zhang, Q. (https://doi.org/10.1007/s00432-012-1244-9>
113. 2010b) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31, 659-666.
< , G. K., Zhu, J. Q., Zhang, J. T., Li, Q., Li, Y., He, J., Qin, Y. W., Jing, Q. (https://doi.org/10.1093/eurheartj/ehq013>
114. 2013) Characterization and identification of novel serum microRNAs in sepsis patients with different outcomes. Shock 39, 480-487.
< , H. J., Zhang, P. J., Chen, W. J., Jie, D., Dan, F., Jia, Y. H., Xie, L. X. (https://doi.org/10.1097/SHK.0b013e3182940cb8>
115. 2010a) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259.
< , K., Zhang, S., Weber, J., Baxter, D., Galas, D. J. (https://doi.org/10.1093/nar/gkq601>
116. 2012a) Comparing the microRNA spectrum between serum and plasma. PLoS One 7, e41561.
< , K., Yuan, Y., Cho, J. H., McClarty, S., Baxter, D., Galas, D. J. (https://doi.org/10.1371/journal.pone.0041561>
117. 2012b) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7, e44398.
< , Q., Huang, Z., Ni, S., Xiao, X., Xu, Q., Wang, L., Huang, D., Tan, C., Sheng, W., Du, X. (https://doi.org/10.1371/journal.pone.0044398>
118. 2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63.
< , Z., Gerstein, M., Snyder, M. (https://doi.org/10.1038/nrg2484>
119. 2010) The micro-RNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741.
< , J. A., Baxter, D. H., Zhang, S., Huang, D. Y., Huang, K. H., Lee, M. J., Galas, D. J., Wang, K. (https://doi.org/10.1373/clinchem.2010.147405>
120. 2015) Detection of circulating miRNA levels in schizophrenia. Am. J. Psychiatry appiajp201514030273.
, H., Yuan, Y., Liu, S., Wang, C., Yang, F., Lu, Z., Wang, C., Deng, H., Zhao, J., Shen, Y., Zhang, C., Yu, X., Xu, Q. (
121. 2011) Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin. J. Cancer 30, 407-414.
< , J., Gao, W., Zhu, C. J., Liu, Y. Q., Mei, Z., Cheng, T., Shu, Y. Q. (https://doi.org/10.5732/cjc.010.10522>
122. 2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc. Natl. Acad. Sci. USA 110, 4255-4260.
< , Z., Ben-Dov, I. Z., Elias, R., Mihailovic, A., Brown, M., Rosenwaks, Z., Tuschl, T. (https://doi.org/10.1073/pnas.1214046110>
123. 2014) U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem. Biophys. Res. Commun. 454, 210-214.
< , M., Zeng, Y., Yang, R., Xu, H., Chen, Z., Zhong, J., Xie, H., Xu, Y., Zeng, X. (https://doi.org/10.1016/j.bbrc.2014.10.064>
124. 2011) Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 50, 136-142.
< , J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., Lin, D. (https://doi.org/10.1002/mc.20712>
125. 2014) Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension 63, 1276-1284.
< , P., Zhao, Y., Liu, M., Wang, Y., Wang, H., Li, Y. X., Zhu, X., Yao, Y., Wang, H., Qiao, J., Ji, L., Wang, Y. L. (https://doi.org/10.1161/HYPERTENSIONAHA.113.02647>
126. 2011) Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol. 32, 583-588.
< Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., Gezer, U. (https://doi.org/10.1007/s13277-011-0154-9>
127. 1999) Effects of heparin on polymerase chain reaction for blood white cells. J. Clin. Lab. Anal. 13, 133-140.
< , M., Tatsumi, N., Nathalang, O., Yamada, T., Tsuda, I. (https://doi.org/10.1002/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0>
128. 2012) Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J. 2, e53.
< , S., Ohyashiki, J. H., Ohyashiki, M., Umezu, T., Suzuki, K., Inagaki, A., Iida, S., Ohyashiki, K. (https://doi.org/10.1038/bcj.2011.51>
129. 2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4, e4722.
< , A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., Farber, D. B. (https://doi.org/10.1371/journal.pone.0004722>
130. 2014) Co-isolation of extracellular vesicles and highdensity lipoproteins using density gradient ultracentrifugation. J. Extracell. Vesicles 3, 1-5.
< , Y., Levels, J., Grootemaat, A., Sturk, A., Nieuwland, R. (https://doi.org/10.3402/jev.v3.23262>
131. 2011) Circulating microRNA is a biomarker of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 53, 26-33.
< , A. M., Thayu, M., Hand, N. J., Horner, A., Leonard, M. B., Friedman, J. R. (https://doi.org/10.1097/MPG.0b013e31822200cc>
132. 2014) MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer 14, 200.
< , S., Kim, E., Zhu, Y., Zhao, J. T., Sidhu, S. B., Robinson, B. G., Soon, P. S. (https://doi.org/10.1186/1471-2407-14-200>
133. 2013) Downregulation of miRNA-30a in human plasma is a novel marker for breast cancer. Med. Oncol. 30, 477.
< , R. C., Zhang, W., Yan, X. Q., Ye, Z. Q., Chen, E. D., Huang, D. P., Zhang, X. H., Huang, G. L. (https://doi.org/10.1007/s12032-013-0477-z>
134. 2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81.
< , A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., Wang, S., Olson, E. N., Schober, A., Weber, C. (https://doi.org/10.1126/scisignal.2000610>
135. 2013) Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp. Mol. Pathol. 94, 115-120.
< , A., Li, G., Péoc’h, M., Genin, C., Gigante, M. (https://doi.org/10.1016/j.yexmp.2012.10.005>
136. 2013) Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One 8, e83025.
< , G., Wang, H., Zhang, X., Yang, Y., Wang, L., Du, L., Li, W., Li, J., Qu, A., Liu, Y., Wang, C. (https://doi.org/10.1371/journal.pone.0083025>
137. 2013) Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One 8, e56718.
< , F., Cao, X., Xie, X., Wang, B., Dong, W., Gu, W., Ling, Y., Wang, R., Yang, Y., Liu, Y. (https://doi.org/10.1371/journal.pone.0056718>
138. 2013) Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Clin. Chim. Acta 424, 66-72.
< , S., Cao, L., Zhu, J., Kong, L., Jin, J., Qian, L., Zhu, C., Hu, X., Li, M., Guo, X., Han, S., Yu, Z. (https://doi.org/10.1016/j.cca.2013.05.010>
139. 2009) Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2, 89.
< , W., Qin, W., Atasoy, U., Sauter, E. R. (https://doi.org/10.1186/1756-0500-2-89>
140. 2010) Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 3, 447-450.
< , A., Vendrig, T., Hopmans, E. S., van Eijndhoven, M., Middeldorp, J. M., Pegtel, D. M. (https://doi.org/10.4161/cib.3.5.12339>